Stock SNDX SYNDAX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Syndax Pharmaceuticals, Inc.

Equities

SNDX

US87164F1057

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
21.06 USD +2.38% Intraday chart for Syndax Pharmaceuticals, Inc. +1.25% -2.55%
Apr. 08 Syndax Pharmaceuticals, Inc. Presents Positive Pediatric Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary Session CI
Mar. 28 Syndax Pharmaceuticals, Inc. Announces Completion of Enrollment in AUGMENT-101 Pivotal Trial Cohort of Patients with Relapsed/Refractory mNPM1 Acute Myeloid Leukemia CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Bullish

Bullish

Resistance 21.92 24.57 24.57
Spread/Res.-3.92%-14.29%-14.29%
Spread/Supp.+2.78%+19.19%+27.79%
Support 20.49 17.67 16.48

Technical Rankings Surperformance

Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes
  1. Stock Market
  2. Equities
  3. SNDX Stock
  4. Charts Syndax Pharmaceuticals, Inc.